1 杜忠东,陈笑征.川崎病流行病学研究进展[J].中国实用儿科杂志,2017,32(8):565-569. 2 余艳萍,阿布来提.阿布都哈尔.川崎病诊断和治疗新进展[J].中华临床医师杂志(电子版),2016,10(4):566-570. 3 韩鹏,刘铜林.新生儿不完全川崎病1例报告并文献复习[J].临床儿科杂志,2017,3(35):176-178. 4 Han R K,Sinclair B,Newman A,et al.Recognition and management of Kawasaki disease[J].CMAJ,2000,162(6):807-812. 5 李瑞燕,李晓辉,吴泰相.川崎病与病原微生物关系的meta分析[J].临床儿科杂志,2013,31(1):69-72. 6 Tremoule T AH,Jain S E.Evolution of laboratory values in patients with Kawasaki disease[J].Pediatr Infect Dis J,2011,30(12):1022-1026. 7 Belser A S,Takahashi M,Baker A L,et al.A predictive instrument for coronary artery aneurysms in Kawasaki disease[J].AM J Cardiol,1998,81(9):1116-1120. 8 Nweburger J W,Takahashi M,Gerber M A,et al.Diagnosis,treatment and long-term management of Kawasaki disease:a statement for health professionals from the committee on rheumatic fever,endocarditis,and Kawasaki disease,council on cardiovascular disease in the young.American heart association[J]. Pediatrics,2004,114(6):1708-1733. 9 彭昌,罗月静. 儿童不完全川崎病的临床特点分析[J].中国当代儿科杂志,2016,18(11):1111-1114. 10 李晨,施红英.谷丙、谷草转氨酶与丙球无反应型川崎病相关性的Meta分析[J].浙江医学,2016,38(22):1787-1794. 11 Soeters P B.Rationale for albumin infusions[J].Curr Opin Clin Nutr Metab Care,2009,12(3):258-264. 12 胡建芬,罗海燕,隆彩霞,等.儿童川崎病低蛋白血症与炎症反应及肝功能的关系研究[J].儿科药学杂志,2015,21(1):3-5. 13 Davies S,Sutton N,Blackstock S,et al.Predicting IVIG resistance in UK Kawasaki disease[J].Arch Dis Child,2015,100(4):366-368. 14 Tseng C K,Fu Y C,Fu L S,et al.Clinical spectrum of Kawasaki disease in infants[J].Chin Med J(Taibei),2001,64(3):168-173. |